グローバル呼吸器系診断試薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

According to YH Research, the global market for Respiratory Diagnostic Reagents should grow from US$ 6667 million in 2025 to US$ 10120 million by 2032, with a CAGR of 6.2% for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Respiratory Diagnostic Reagents are in vitro diagnostic products used to detect viruses, bacteria, and other pathogens in the human respiratory system through samples such as throat swabs, nasal swabs, sputum, and bronchoalveolar lavage fluid. These reagents employ various technological approaches—including nucleic acid amplification (PCR and isothermal amplification), antigen–antibody immunoassays, multiplex pathogen panels, and molecular point-of-care testing (POCT). They are widely used in hospital laboratories, emergency departments, primary healthcare settings, independent clinical laboratories, and public health surveillance systems. The reagents cover common pathogens such as influenza, RSV, adenovirus, Mycoplasma, and Streptococcus pneumoniae, as well as emerging infectious agents, enabling early diagnosis, differential diagnosis, and disease monitoring. Driven by shifts in disease patterns, antimicrobial stewardship policies, and the rapid adoption of POCT technologies, respiratory diagnostic reagents are evolving toward higher multiplexing, faster turnaround, home-based testing formats, and deeper integration with digital health platforms.In 2024, global Respiratory Diagnostic Reagent production reached approximately 1677 m units, with an average global market price of around US$ 3.5 perunit.The average gross   profit margin of this product is 55%.

The respiratory diagnostic reagents market is entering a phase of structural growth, fueled by shifts in respiratory disease patterns, population aging, improved primary-care capabilities, and rising demand for precise clinical diagnosis. The high transmissibility and seasonality of respiratory pathogens drive the need for fast, accurate, and scalable testing solutions across healthcare institutions. At the same time, public-health programs continue to strengthen surveillance networks, accelerating adoption of multiplex assays and automated systems. The growing maturity of POCT technologies is further extending respiratory testing from centralized labs to emergency units, fever clinics, community healthcare settings, and even home environments, unlocking new growth potential.

Despite strong growth momentum, the market faces tightening regulatory requirements, rapid technological evolution, and heterogeneous clinical usage scenarios. Regulatory frameworks differ widely across countries, imposing high entry and compliance costs. Continuous innovation is needed for companies to maintain competitive product performance. Clinical workflow variations, budget constraints, and compatibility with existing equipment can affect adoption across hospital tiers. Furthermore, certain upstream biological materials remain highly concentrated in supply, resulting in cost volatility and supply-chain uncertainty.

Downstream demand is expanding across multiple clinical and non-clinical scenarios. Tertiary hospitals increasingly adopt high-sensitivity nucleic acid assays and multiplex panels to improve diagnostic efficiency for complex respiratory infections. Primary-care and rapid-diagnosis settings prefer fast immunoassays and molecular POCT solutions that support high-throughput and immediate decision-making. Independent laboratories are driving demand for automation and diversified test portfolios as they scale operations. In the consumer health sector, home-based respiratory testing and connected digital platforms are gaining traction, enabling “medical-grade testing” to penetrate everyday health management.

Key raw materials include high-activity enzymes, sequence-specific primers and probes, antibodies, antigens, buffer systems, and microsphere materials—each requiring high technical precision and strict lot-to-lot consistency. Enzymes and molecular-biology reagents rely on advanced protein-engineering technologies and purified extraction platforms, forming major cost components of nucleic-acid kits. Antibody and antigen production depends on robust cell-culture systems and stringent quality control, determining the performance of immunoassays. Although local supply-chain development is accelerating, dependence on advanced enzymes, labels, and multiplex-related consumables persists, making upstream materials a critical foundation of industry competitiveness.

This report studies and analyses global Respiratory Diagnostic Reagents status and future trends, helps the client to determine the Respiratory Diagnostic Reagents market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Respiratory Diagnostic Reagents, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Respiratory Diagnostic Reagents market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (K Units)
(2) Global Respiratory Diagnostic Reagents sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(3) Japan Respiratory Diagnostic Reagents sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(4) Global Respiratory Diagnostic Reagents key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Respiratory Diagnostic Reagents key producing regions, capacity, production, and year over year growth
(6) Respiratory Diagnostic Reagents industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Abbott
    Roche
    Danaher
    Quidel
    Siemens Healthineers
    Thermo Fisher Scientific
    Denka Co.,Ltd.
    BioMerieux
    Becton Dickinson
    Bio-Rad Laboratories
    Sansure Biotech
    ShuoShi Biotech
    Antu Biotech
    DaAn Gene
    Sinbe
    Guangzhou KBP Biotech
    Berge Medical
    Hantang Biotech
    Getein Biotech
    Wuhan Easy Diagnosis
    Guangzhou Wondfo Biotech
    Zhijiang Bio
    Zhuocheng Huisheng
    Innovita

Market segment by Type, covers
    Nucleic Acid Testing
    Antigen Testing
    Antibody Testing
    Other

Market segment by Target Pathogen, covers
    Viral Assays
    Bacterial Assays
    Atypical Pathogen Assays
    Other

Market segment by Sample Type, covers
    Nasopharyngeal/Nasal Swabs
    Throat Swabs
    Sputum
    Other

Market segment by Application, can be divided into
    Hospital
    Third-party Laboratory
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Respiratory Diagnostic Reagents product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Respiratory Diagnostic Reagents market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Respiratory Diagnostic Reagents market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Respiratory Diagnostic Reagents, percent & CAGR, 2021-2032
Chapter 5: Respiratory Diagnostic Reagents industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions